Anavex Life Sciences
AVXL
144 hedge funds and large institutions have $206M invested in Anavex Life Sciences in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 44 reducing their positions, and 14 closing their positions.
65% more call options, than puts
Call options by funds: $9.63M | Put options by funds: $5.85M
21% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 14
2% more funds holding
Funds holding: 141 → 144 (+3)
7% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 44
3.47% less ownership
Funds ownership: 34.74% → 31.27% (-3.5%)
11% less capital invested
Capital invested by funds: $232M → $206M (-$25.9M)
Top Buyers
| 1 |
Jane Street
New York
|
+$3.54M |
| 2 |
BlackRock
New York
|
+$1.73M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.61M |
| 4 |
Millennium Management
New York
|
+$1.45M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$766K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$10.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4.95M |
| 3 |
Goldman Sachs
New York
|
-$3.01M |
| 4 |
Citigroup
New York
|
-$2.18M |
| 5 |
Two Sigma Advisers
New York
|
-$1.32M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$106K | -12,295 | Closed |
|
|
OCM
152
Orion Capital Management
Coronado,
California
| – | -$81.4K | -9,500 | Closed |
|
|
ASN
153
Advisory Services Network
Atlanta,
Georgia
| – | -$41.6K | -4,850 | Closed |
|
|
DFCM
154
Dark Forest Capital Management
San Juan,
Puerto Rico
| – | -$5.15K | -601 | Closed |
|
|
WP
155
WealthPLAN Partners
Omaha,
Nebraska
| – | -$4.29K | -500 | Closed |
|
|
AIM
156
Anchor Investment Management
Columbia,
South Carolina
| – | -$1.91K | -223 | Closed |
|
|
AAS
157
Ameritas Advisory Services
Lincoln,
Nebraska
| – | -$857 | -100 | Closed |
|
AVXL Hedge Fund Activity: Q2 2023 in Review
144 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q2 2023, worth a combined $206M — down 11% from $232M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new AVXL positions and 14 closed out — a net gain of 3 holders — while 47 added to existing stakes and 44 trimmed.
The largest buyer was Jane Street, adding an estimated $3.54M. The largest seller was State Street, cutting an estimated $10.9M.
- 144 institutional investors held Anavex Life Sciences (AVXL) as of Q2 2023, up from 141 in Q1 2023.
- Funds reported $206M of Anavex Life Sciences stock for Q2 2023, down 11% quarter-over-quarter.
- 17 funds opened new Anavex Life Sciences positions in Q2 2023 and 14 closed out, a net change of +3 holders.
- The largest Anavex Life Sciences buyer in Q2 2023 was Jane Street, an estimated $3.54M added.
- The largest Anavex Life Sciences seller in Q2 2023 was State Street, an estimated $10.9M sold.
Based on aggregated 13F filings for Q2 2023.